A detailed history of Alpha Centric Advisors LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 3,337 shares of BSX stock, worth $258,817. This represents 0.16% of its overall portfolio holdings.

Number of Shares
3,337
Previous 3,653 8.65%
Holding current value
$258,817
Previous $211,000 8.06%
% of portfolio
0.16%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$57.6 - $68.62 $18,201 - $21,683
-316 Reduced 8.65%
3,337 $228,000
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $26,265 - $31,217
-540 Reduced 12.88%
3,653 $211,000
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $8,331 - $9,076
-166 Reduced 3.81%
4,193 $221,000
Q2 2023

Aug 08, 2023

BUY
$49.72 - $54.64 $216,729 - $238,175
4,359 New
4,359 $235,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $111B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.